Literature DB >> 27342208

Transcatheter Simultaneous Double-Transapical Access for Paravalvular Mitral Leak Closure Using the Occlutech PLD.

Vincenzo Pestrichella, Antonio Pignatelli, Rossella Alemanni, Rosamaria Montesanti, Maurizio Braccio, Francesco Greco, Pierpaolo D'Ambruoso, Cataldo Davide Memmola, Mauro Cassese, Gaetano Contegiacomo, Rodrigo Bagur1.   

Abstract

A 67-year-old patient with rheumatic heart valve disease had undergone two cardiac surgeries at the age of 30 years, then re-do with mitral valve replacement at 50 years. She presented with congestive heart failure and hemolytic anemia. Doppler echocardiography showed moderate-severe mitral regurgitation due to paravalvular mitral valve leak (PVML) and severe pulmonary hypertension. Transesophageal echocardiography demonstrated severe PVML secondary to a large 20 mm-long PVML defect. Due to comorbidities, the heart team deemed a third reoperation at very high surgical risk; therefore, the patient was considered most suitable for a transcatheter approach to PVML closure. Two Occlutech paravalvular leak devices were successfully delivered using a simultaneous double-transapical access with double-wire technique.

Entities:  

Mesh:

Year:  2016        PMID: 27342208

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN: 1042-3931            Impact factor:   2.022


  3 in total

Review 1.  Transapical approach in transcatheter cardiovascular interventions.

Authors:  Minoru Tabata
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-01-25

2.  Transcatheter Closure of a Paravalvular Leak Guided by Transesophageal Echocardiography and Three-Dimensional Printing.

Authors:  Chennian Xu; Yang Liu; Mengen Zhai; Ping Jin; Lanlan Li; Yanyan Ma; Jian Yang
Journal:  Front Cardiovasc Med       Date:  2022-05-20

3.  Transcatheter Closure of Mitral Paravalvular Leak via Multiple Approaches.

Authors:  Yang Liu; Chennian Xu; Peng Ding; Jiayou Tang; Ping Jin; Lanlan Li; Min Chen; Xin Meng; Hongliang Zhao; Jian Yang
Journal:  J Interv Cardiol       Date:  2021-03-02       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.